Merck KGaA (ETR:MRK) Trading 0.4% Higher – Still a Buy?

Merck KGaA (ETR:MRKGet Free Report) rose 0.4% during trading on Wednesday . The company traded as high as €121.20 and last traded at €120.55. Approximately 146,438 shares changed hands during mid-day trading, The stock had previously closed at €120.10.

Merck KGaA Price Performance

The stock’s 50 day simple moving average is €115.48 and its two-hundred day simple moving average is €112.69. The stock has a market cap of $53.68 billion, a price-to-earnings ratio of 19.80, a P/E/G ratio of 2.37 and a beta of 0.71.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.

Recommended Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.